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lin-2 (Cav2) ( 4 ), cavin-1 ( 5–7 ), and probably, cavin-2 ( 8 ). 
The caveolins are small integral membrane proteins ( 4 ), 
and the cavins are peripheral membrane proteins without 
enzymatic activity that are tightly associated with caveolae 
( 2, 9 ). Mice lacking caveolin-1 generated by gene knock-
out technology are lean, have abnormally small fat cells, 
and are insulin resistant ( 10 ), which is a phenotype mir-
rored in humans with inactivating Cav1 mutations ( 11, 
12 ). Among other pathologies that they harbor, mice ( 6 ) 
and humans ( 13–16 ) lacking functional cavin-1 are lean, 
lipodystrophic, and insulin resistant. These facts suggest 
that caveolae serve one or more functions specifi c to adi-
pocytes and their lipid metabolism. 
 Caveolae are a subset of so-called membrane lipid raft 
domains that are often experimentally defi ned by their re-
sistance to solubilization by brief exposure to nonionic de-
tergents ( 17 ). FA anions are also weak detergents at 
physiological pH and are traffi cked in abundant amounts 
in and out of fat cells. Consequently, we and others have 
suggested that caveolae could serve to protect adipocytes 
(and other cells) from the possible toxic effects of FA by 
serving as a membrane “buffer” for these molecules ( 18–
20 ). Indeed, we showed that HEK293 cells overexpressing 
caveolin-1 or caveolin-3 were resistant to the toxic effects 
of prolonged incubation with physiologically high levels of 
FA ( 20 ). However, compared with adipocytes, these cells 
lack the capacity to store large amounts of triglycerides, 
and they also lack the hormone sensitive lipolytic protein 
machinery of the fat cell ( 21 ). Thus, while the HEK293 
cell line serves as a useful model system for a variety of 
purposes, it does not refl ect the robust FA traffi cking and 
lipid metabolism of the adipocyte, the physiologically rel-
evant cell in this regard. Consequently, we took advantage 
of the caveolin-1-null mouse ( 5 ) to create an adipocyte cell 
line from embryonic fi broblasts, and we “rescued” these 
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 Proper functioning of adipocytes with regard to fatty 
acid (FA) storage and release is an essential aspect of fuel 
homeostasis, and dysregulation of these processes can lead 
to obesity and type 2 diabetes mellitus ( 1 ). Along with 
their characteristically large lipid droplets, striking fea-
tures of fat cells are cell surface structures called caveolae 
or little caves, small (50-100 nM) invaginations of the 
plasma membrane into the cytosol ( 2 ) that are especially 
abundant in this cell type, constituting as much as 50% of 
the surface area ( 3 ). In nonmuscle cells, caveolae are 
formed due to the expression of caveolin-1 (Cav1), caveo-
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cells were grown in DMEM as above, but with 10% FBS to 70% 
confl uence in 100 mm diameter dishes, at which stage they were 
transfected with a DNA-FuGENE cocktail consisting of 54 µl Fu-
gene 6 transfection reagent, 6 µg retrovirus constructs, 6 µg pV-
Pack-VSV-G vector, 6 µg pVPack-GAG-POL vector, and DMEM 
without FBS to fi nal volume of 200 µl. As a control, cells were 
transfected with pBabe-puro empty vector. Twenty-four h later, 
the medium was replaced with 6 ml fresh DMEM containing 10% 
FBS. After an additional 24 h, the supernatant containing high-
titer retrovirus was collected and fi ltered through a 0.45 µm pore-
sized fi lter. The viral fi ltrates were added to the target cells. After 
infection, cells were selected for fi ve days in complete medium 
containing puromycin at a fi nal concentration of 2.5   g/ml. Fol-
lowing selection, cells were maintained in medium containing 
1.25   g/ml puromycin. Stable expression in the target cell popu-
lation was confi rmed by Western blot analysis. 
 Preparation of whole cell extracts 
 Cells were washed three times with PBS and incubated for 30 
min on ice with iced-cold RIPA buffer containing 50 mM Tris 
(pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, 0.1% SDS, and a protease inhibitor cocktail (Aprotinin 
10   g/ml, Pepstatin 1   g/ml, and Leupeptin 5   g/ml; American 
Bioanalytical, Natick, MA). Lysates were vortexed and spun for 
20 min at 16,000  g at 4°C. Protein concentrations were deter-
mined in the supernatant using bicinchoninic acid (BCA) re-
agent (Pierce, Rockford, IL). 
 Gel electrophoresis and immunoblotting 
 Proteins were separated by SDS-PAGE (acrylamide; National 
Diagnostics, Atlanta, GA) and electrophoretically transferred to 
polyvinylidene difl uoride membrane (Bio-Rad, Hercules, CA). 
The membrane was then blocked with 10% nonfat dry milk in 
PBS containing 0.5% Tween-20 for 1 h at room temperature. Pri-
mary antibodies were detected using secondary antibodies conju-
gated to horseradish peroxidase (Sigma) and chemiluminescence 
substrate (PerkinElmer Life Sciences, Boston, MA). 
 Lipolysis 
 Cells were grown to confl uence in 6-well plates and induced to 
differentiate as described above. On the day of the experiment, 
adipocytes were preincubated for 4 h in serum-free DMEM con-
taining 0.5% fatty acid free BSA (American Bioanalytical). Cells 
were washed three times with warm DMEM and then treated with 
10 µM   -adrenergic agonist isoproterenol, 20 µM adenylate cy-
clase activator forskolin, or 1 mM dbcAMP. Agonists were pre-
pared in serum-free culture medium containing 0.5% fatty acid 
free BSA, and 1 ml was added to each well. Aliquots were re-
moved at 1, 2, and 4 h of stimulation, and the glycerol content of 
each sample was measured using the Triglyceride (GPO) Re-
agent Set and measured at 540 nm against a set of glycerol stan-
dards as in previous studies ( 20 ). Cells were then washed with 
cold PBS and lysed with a RIPA buffer. The protein concentra-
tion was determined and used to normalize glycerol release. 
Unesterifi ed fatty acids from cells treated as above were mea-
sured in DMEM media without phenol red, and the glucose con-
centration was adjusted to 4.5 g/l using a kit from Waco 
Diagnostics (Richmond, VA). The 4 h time-point samples were 
used for measuring LDH release using QuantiChrom TM Lactate 
Dehydrogenase Kit (DLDH-100; Biosystems, Hayward, CA) per 
manufacturer’s recommendations. 
 Confocal laser-scanning microscopy 
 Cells were grown in 6-well plates to confl uence and were in-
duced to differentiate. On day 8 of differentiation, cells were 
cells by expressing caveolin-1 to compare lipolysis and its 
effects in this context. We show that caveolae protect fat 
cells from the autolysis that results from lipolytic stimula-
tion by several agents, including adrenergic hormones. 
 EXPERIMENTAL PROCEDURES 
 Antibodies 
 A polyclonal antibody against caveolin-1 and monoclonal anti-
caveolin 2 were purchased from BD Transduction Laboratories 
(San Jose, CA), and anti-actin was from Sigma (St. Louis, MO). 
Monoclonal anti-caveolin-1 antibodies were produced in our 
laboratory ( 22 ). Anti-peptide antibodies directed against cavin-1, 
cavin-2, and cavin-3 ( 7, 8 ) were made by 21 st Century Biochemi-
cals (Marlboro, MA). Polyclonal antibodies against perilipin, hor-
mone sensitive lipase (HSL), and adipocyte triglyceride lipase 
(ATGL) were kindly provided by Dr. Andrew Greenberg (Tufts 
University, Boston, MA). Polyclonal anti-aP2 was kindly provided 
by Dr. David Bernlohr (University of Minnesota, Minneapolis, 
MN). Anti-phospho-protein kinase A (PKA) substrate antibody 
was kindly provided by Dr. M. S. Gauthier (Boston University 
School of Medicine, Boston, MA) ( 23 ). 
 Reagents 
 Dexamethasone, 3-isobutyl-1-methylxanthine, and insulin 
were purchased from Sigma. Triglyceride-GPO Reagent Set was 
purchased from Pointe Scientifi c, Inc. (Canton, MI). Isoprot-
erenol, the adenylate cyclase activator, forskolin, and  O -
dibutyryladenosine-3 ′ 5’-cyclic monophosphate (dbcAMP) were 
obtained from Sigma, and the FuGENE 6 transfection reagent 
was purchased from Roche Diagnostics (Indianapolis, IN). 
 Cell culture 
 Primary mouse embryonic fi broblasts (MEF) were obtained 
from wild-type and Cav1-null mice ( 5 ). Cells were grown in Dul-
becco’s modifi ed Eagle’s medium (DMEM; Mediatech, Inc., 
Herndon, VA) that contained a mixture of penicillin (50 units/
ml) and streptomycin (50   g/ml) (Invitrogen, Carlsbad, CA). 
The medium was supplemented with 10% fetal bovine serum 
(FBS; Invitrogen). Cells were immortalized using a 3T3 cell pas-
saging protocol ( 24 ). Cells were passaged continuously every 3 
days and plated at 6 × 10 5 cells per 100 mm dish until the growth 
rate become relatively rapid and cells had a fi broblastic morphol-
ogy (  passage 20 and beyond). Confl uent cells were induced to 
differentiate using a cocktail of insulin (1.7   M), isobutylmeth-
ylxanthine (0.5 mM), dexamethasone (1   M) ( 25 ), and troglita-
zone (5   M) ( 26 ). After 2-3 days, cells were maintained in FBS 
containing 10% FBS and 0.85   M insulin and troglitazone (5 
  M) for 3 days, then in medium containing 10% FBS and trogli-
tazone for a total of 8-10 days. 
 Animals 
 Male Sprague Dawley rats (175 g) were obtained from Charles 
River Labs (Wilmington, MA). Rats were fed ad libitum or fasted 
prior to isolation of primary (epididymal) fat cells and Western 
blot analysis as previously described ( 27 ) and approved by the 
Institutional Animal Care and Use Committee at the Boston Uni-
versity Medical Center. 
 Retroviral vectors 
 The cDNA encoding for mouse caveolin-1 was subcloned into 
BamHI and  Eco RI sites of the pBABE-puro retroviral vector. 
Transfection was done as previously described ( 28 ). HEK-293T 
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 after exposure to the lipolytic agents forskolin and isopro-
terenol, the Cav1-null cells hydrolyzed triglycerides to a 
slightly but signifi cantly higher extent than the Cav1 ex-
pressing cells, and they showed equivalent basal lipolysis. 
 The differences in lipolysis could be explained by a 
number of factors, including differences in lipolytic en-
zyme expression and/or lipolytic signaling. Accordingly, 
we measured expression levels for a number of proteins 
washed three times with PBS, trypsinized, and plated again into 6 
well plates containing coverslips pretreated with 0.1% gelatin 
(Millipore Billerica, MA). After 24 h, cells were fi xed with 3.7% 
formaldehyde in PBS for 20 min at room temperature. Cells were 
permeabilized with solution A (0.1% saponin and 0.4% BSA in 
PBS) for 10 min and then blocked for 1 h at room temperature 
in 5% normal goat serum (Sigma) in PBS. Staining was per-
formed with rabbit polyclonal anti-caveolin-1 antibody overnight 
at a dilution of 1/100 in 1% normal goat serum in PBS. Following 
staining, cells were washed four times with buffer A. Cells were 
incubated with anti-rabbit Cy3-conjugated secondary antibody 
(Jackson ImmunoResearch Laboratories, Inc.) at a dilution of 
1/200 in 1% normal goat serum in PBS. The cells were covered 
in aluminum foil and incubated for 1 h at room temperature. 
The cells were washed again three times with solution A and then 
mounted with Vectashield mounting medium with DAPI (Vector 
Laboratories, Inc., Burlingame, CA). The stained cells were ob-
served using a Zeiss 510 confocal laser-scanning microscope (Carl 
Zeiss, Thornwood, NY). Images were processed using LSM 510 
Image software. 
 RESULTS 
 A permanent preadipocyte cell line was created from 
embryonic fi broblasts obtained from Cav1-null mice ( 5 ) as 
described in Experimental Procedures. These cells were 
then infected with Cav1- or empty vector-expressing retro-
virus. As shown in  Fig. 1A ,  infected cells (+Cav1) expressed 
Cav1, which increased somewhat during differentiation 
but not to the same extent as the endogenous protein in 
3T3-L1 cells ( 29 ), and vector-expressing cells (Cav1-null) 
lacked Cav-1 expression as expected. Cav2 levels were 
greatly reduced in Cav1-null cultured adipocytes and were 
restored by Cav1 expression, as would be expected from 
prior data showing that Cav2 requires Cav1 expression for 
recruitment into caveolae ( 30 ). We also characterized the 
Cav1-null and wild-type cells prior to infection, and these 
appeared identical in appearance and caveolar protein ex-
pression to the vector-transfected and rescued cells, re-
spectively, and had comparable levels of hormonally 
stimulated lipolysis (data not shown). Interestingly, cavin-1 
expression is the same in Cav1-null and rescued (+Cav1) 
cell lines. This protein is obligatory for caveolae formation 
( 5–7 ) and, along with cavin-2 and cavin-3, is a member of 
the cavin family of putative caveolar coat proteins in non-
muscle cells ( 8 ). All three cavin isoforms were expressed 
in the Cav1-null cell line ( Fig. 1A ), although cavin-2 ex-
pression was reduced in the absence of Cav1. The Cav1-
null fat cells were larger and exhibited larger lipid droplets 
than cells harboring Cav1 ( Fig. 1B ). The Cav1 reconsti-
tuted cells closely resembled 3T3-L1 cells in their mor-
phology and lipid droplet size (not shown). Finally, the 
Cav1 rescued cells target this protein to the plasma mem-
brane as shown in  Fig. 1C by immunofl uorescence. 
 The dyslipidemia seen in mice lacking adipocyte caveo-
lae is accompanied by reduced adiposity and higher levels 
of circulating FA and triglycerides ( 6, 10 ); consequently, 
we assessed how the Cav1-null adipocytes in vitro respond 
to lipolytic stimuli by measuring FA and glycerol release 
under basal and stimulated conditions. As shown in  Fig. 2 , 
 Fig.  1. Characteristics of Cav1-null adipocytes and +Cav1 fat cells. 
 A: On the indicated day after induction of differentiation (see Ex-
perimental Procedures), whole cell extracts (20 µg) from cells in-
fected with vector (Cav1-null) or caveolin-1 (+Cav1) were prepared 
and resolved by SDS-PAGE (10% acrylamide). Western blotting was 
performed with the indicated antibodies, and bands were detected 
with horseradish peroxidase–conjugated secondary antibody and 
chemiluminescence. B: On day 10 of differentiation, cells were 
viewed in bright fi eld on an Olympus IX70 microscope (Hama-
matsu, Hamamatsu City, Japan) at 20×. C: On day 10 of differentia-
tion, cells were fi xed and subjected to immunostaining for 
caveolin-1 (rims) and the nucleus (center of cell) as described in 
Experimental Procedures prior to visualization by confocal micros-
copy. All results are representative of three or more independent 
experiments. 
 Fig.  2. Lipolysis is enhanced in Cav1-null adipocytes. Glycerol 
and fatty acid release of fully differentiated Cav1-null and +Cav1 
adipocytes were measured after treatment with the lipolytic stimuli, 
10   M isoproterenol (Iso), and 20   M forskolin (Forsk), for 4 h. 
* P   0.05 ± SD for four independent determinations carried out in 
duplicate or triplicate. 
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which is consistent with our hypothesis concerning the cy-
toprotective effects of caveolins and caveolae. 
 A corollary regarding this protective effect is that the 
expression of caveolae-related proteins might be acutely 
increased in vivo under conditions of high circulating FA 
(e.g., fasting), as had been shown for caveolin-1 in mice 
( 35 ) and, more recently, for cavin-1 ( 36 ), in both cases mea-
sured separately from other caveolar proteins. Accordingly, 
we subjected rats to a fast for three days and measured 
Cav1, cavin-1, cavin-2, and cavin-3 levels as well as Glut4 
and Glut1 protein expression. As we showed previously, 
involved in adipocyte FA lipolysis in Cav1 reconstituted 
and Cav1-null cell lines as a function of time of differentia-
tion, with day 0 being the fi broblast state and day 10 being 
the fully differentiated state ( Fig. 3 ).  There were no differ-
ences in the two cell lines in expression levels for the lipid 
droplet-associated proteins adipocyte triglyceride lipase 
(ATGL) and perilipin, which are involved in lipolysis, or in 
HSL or the fatty acid binding protein aP2. As a further 
control, the Glut4 storage vesicle (GSV) ( 31 ) proteins, in-
sulin-responsive aminopeptidase, and Glut4, as well as the 
mitochondrial proteins, uncoupling protein 1 and cyto-
chrome oxidase IV, were measured and found to be un-
changed (data not shown). 
 We then determined if hormone-dependent lipolytic 
signaling was altered in the Cav1-null adipocytes. As shown 
in  Fig. 4 ,  there were no apparent differences between the 
two cell lines in the extent of phosphorylation as assayed 
by a Western blot for PKA phosphorylation sites. Perilipin 
phosphorylation ( Fig. 4 , arrowhead), the rate limiting step 
in lipolysis ( 32, 33 ), was the same in response to the three 
lipolytic stimuli, namely, isoproterenol, dbcAMP, and for-
skolin, indicated in  Fig. 4 . Thus, the presence or absence 
of caveolae seems to be the major and possibly only factor 
that affected the rate of fatty acid release in these two adi-
pocyte cell lines. 
 We previously hypothesized that the detergent-resistant 
nature of caveolae and caveolin-dependent lipid rafts 
would protect cells against the cytotoxic effects of high FA 
concentrations. We confi rmed this hypothesis in HEK293 
cells transfected with Cav1 or Cav3 by showing they were 
protected from the toxic effects of prolonged exposure to 
high levels of exogenous FA ( 20 ). HEK cells do not signifi -
cantly express enzymes for FA storage nor do they possess 
hormonally sensitive lipolytic machinery. We wished to 
test the ability of adipocytes to resist lipotoxicity produced 
by endogenous FA, as these are the most physiologically 
relevant cells that would see the highest levels of FA upon 
lipolytic stimulation in vivo. Indeed, as shown in  Fig. 5 ,  the 
release of lactic dehydrogenase (LDH), a measure of 
plasma membrane integrity ( 34 ), is greater in adipocytes 
lacking caveolae (Cav1-null) than in rescued cells (+Cav1), 
 Fig.  3. Lipolytic enzyme levels are the same in Cav1-null and 
+Cav1 adipocytes. Cells differentiated as in  Fig. 1 were lysed, and 
equal proteins amounts were subjected to SDS-PAGE and Western 
blotting with the antibodies indicated. Shown is a blot representa-
tive of three independent experiments. Statistical analysis of 
scanned gels revealed no signifi cant differences in day 10 levels for 
the proteins shown. 
 Fig.  4. The absence of Cav1 does not affect PKA signaling. Dif-
ferentiated adipocytes (day 8) were incubated with serum-free 
DMEM containing 0.5% fatty acid free BSA for 3 h, followed by 
treatment with or without isoproterenol (10 µM), dbcAMP (1 mM), 
or forskolin (20 µM) for 4 h. Then cell lysates were prepared, sub-
jected to SDS-PAGE, and immunoblotted with antibodies recogniz-
ing phosphorylated serine and threonine residues of PKA substrate. 
The immunoblot shown is representative of three independent 
experiments. 
 Fig.  5. Caveolae protect adipocytes from autolysis. On day 10 of 
differentiation, vector-transfected cells (Cav1-null, open bars) and 
Cav1-transfected cells (+Cav1, closed bars) were incubated in 
DMEM media without phenol red and with a glucose concentra-
tion of 25 mM. After 4 h incubation in the presence or absence of 
isoproterenol (Iso) and forskolin (Forsk), lactic dehydrogenase 
(LDH) released into the media was measured as described in Ex-
perimental Procedures. The data are the mean + SEM from three 
or four independent experiments carried out in triplicate, * P   
0.03 for Iso; * P   0.003 for Forsk. 
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of lipid release ( Fig. 2 ). Moreover, we saw neither differ-
ences in any of the enzymatic machinery for lipolysis nor 
alteration of lipolytic signaling ( Figs. 3 and 4 ). The prod-
ucts of lipolysis, glycerol and FAs, are measured in the ex-
tracellular milieu and need to cross the plasma membrane. 
Previously, we have shown that, in HEK293 cells trans-
fected with caveolin-1 or caveolin-3, the transfected cells 
had the property of modulating transmembrane FA move-
ment by sequestering FAs in the inner leafl et of the plasma 
membrane where caveolins are inserted ( 18, 20 ). Because 
the HEK cells lack hormonally sensitive lipolytic protein, 
we can measure signifi cant FA movement only in the di-
rection of FA uptake; however, in fat cells, we can measure 
FA release, one of the most physiologically relevant situations 
where autolysis might be a problem. Our results ( Fig. 2 ), 
together with the data of  Figs. 3 and 4 , are consistent with 
the interpretation that the reduced extent of lipid release 
measured extracellularly in the +Cav1 versus Cav1-null 
cells can be attributed to the enhanced FA sequestration 
in caveolae in the former cell line. Importantly, the condi-
tion under which these activities would likely be most 
physiologically relevant is prolonged hormone-stimulated 
lipolysis, which was shown to result in autolysis in primary 
rat adipocytes as measured by LDH release ( 34 ). We used 
the same assay as in Ref.  34 to show that caveolae do in-
deed protect against this form of lipotoxicity in cultured 
cells ( Fig. 5 ). 
 Note, however, that the extent of lipid release from the 
Cav1-null fat cells was roughly proportional to the LDH 
release as normalized to total protein. However, the Cav1-
null cells were signifi cantly bigger, nearly twice the diam-
eter of the Cav1-expressing cells. Thus, although it is not 
readily feasible to normalize lipid release to total cell sur-
face area due to the irregular shape of the cultured fat cell, 
FA release normalized to cell surface would actually be less 
per a given surface area in the Cav1-null cells compared 
with the Cav1-expressing cells. Thus these data are consis-
tent with our interpretation that caveolins/caveolae pro-
tect the cells from lipotoxicity. 
 Finally, we showed that in vivo conditions of high circu-
lating FA (namely, fasting) led to upregulation of the 
structural components of caveolae ( Fig. 6 ), including re-
cently characterized cavin family members, cavin-1, cavin-2, 
and cavin-3 ( 8, 37, 38 ). These results are consistent with a 
cytoprotective effect of caveolae in adipocytes that may 
also apply to other cells, such as endothelial cells and the 
lung epithelium ( 39 ), in the latter case, as a protection 
against endogenously produced surfactant. These possi-
bilities can be experimentally addressed in a fashion simi-
lar to ours. 
 Are there roles for caveolae and their structural compo-
nents in adipocyte lipid metabolism other than to modu-
late FA fl ux and protect cell integrity? Several investigators 
have reported that caveolin-1 is associated with the lipid 
droplet, although its function is not known ( 35, 40 ). It has 
also been shown that lipogenesis can occur in a subset of 
membranes enriched in caveolae ( 19 ). More recently, 
cavin-1 has been implicated in playing a regulatory role in 
hormonally stimulated lipolysis ( 36 ). Our data demon-
fasting causes a loss of Glut4 and an increase in Glut1 ( 27 ), 
and we show in this study that Cav1, cavin-1, cavin-2, and 
cavin-3 are increased after three days of fasting ( Fig. 6 )  , 
indicating that the known caveolar protein constituents 
are coordinately regulated under these conditions. Given 
the interdependence of caveolins and cavin-1 for caveolae 
formation ( 2 ), these data suggest that the number of cave-
olae increases under these conditions. 
 DISCUSSION 
 The role of caveolae in adipocyte fatty acid metabolism 
is underscored most dramatically by the phenotype of cav-
eolae-defi cient mice ( 6, 10 ) and humans ( 11–13, 15 ). Both 
species exhibit reduced fat mass and hyperlipidemia, and 
the mice have smaller adipocytes and a blunted hormone-
induced lipolytic response when isolated as primary cells 
( 35 ) (S. Y. Ding, S. Fried, and P. F. Pilch, unpublished ob-
servations). The latter result might be surprising, as one 
could imagine that an elevated rate of lipolysis could ac-
count for the hyperlipidemia. The in vivo situation is com-
plicated by the fact that the hyperlipidemia likely precedes 
the elevated insulin levels and insulin resistance observed 
in the knockout mice, and these conditions likely develop 
shortly after birth and well before the 8-12 week time when 
metabolic parameters were fi rst assessed. In addition these 
mice have reduced leptin and adiponectin levels ( 6, 10 ) 
and, most likely, alterations in other hormones, all of 
which could complicate interpretation of the in vivo 
analysis. 
 As a consequence, we used cultured murine adipocytes 
obtained from Cav-1-null MEFs to study lipolysis, and we 
compared them with the same cells into which Cav-1 had 
been reintroduced. Compared with controls, the Cav1-
null fat cells showed a small but signifi cant enhancement 
 Fig.  6. Fasting induces caveolae formation. Rats were fasted for 
no, one, or three days. Primary fat cells were isolated and lysed. 
Lysates (10   g protein) were subjected to SDS-PAGE and Western 
blotting as in previous fi gures. Shown is a representative of three 
experiments (one rat per time point) with actin, cavin-1, Cav1, and 
Glut4 and two experiments with cavin-2 and cavin-3. The gels were 
scanned for Cav1, cavin-1, Glut4, and actin using NIH Image 1.63 
software. The day 0 value was normalized to actin and set to 1.0. 
The proteins levels for Cav1, cavin-1, and Glut4 were changed by 
2.5-fold ± 0.3, 2.9-fold ± 0.1, and 0.4-fold ± 0.2, respectively.  P   
0.05 for day 0 versus day 3 for the three indicated proteins. 
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